Lung Diseases  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00356122: Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Completed
2
53
US
Docetaxel, Oxaliplatin, Bevacizumab
Sanofi, Genentech, Inc.
Non-Small Cell Lung Cancer
08/10
08/10
Taxelox, NCT01222312 / 2008-002197-35: Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel

Completed
2
88
Europe
Cisplatin, Oxaliplatin, Eloxatin, Docetaxel, Taxotere
Krankenhaus Nordwest
Non Small Cell Lung Cancer
10/11
11/11
BELOXAN, NCT01243775: BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC

Completed
2
33
RoW
Belotaxel, Docetaxel, Belloxa, Oxaliplatin
Chonnam National University Hospital, Chong Kun Dang Pharmaceutical
Non-Small Cell Lung Cancer
01/13
01/13

Download Options